ArticleAmerican journal of translational research2025
Comparison of the efficacy and safety of pulsed dye laser, narrow-band intense pulsed light, and broad-band intense pulsed light in the treatment of erythematotelangiectatic rosacea.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Real-time vascular monitoring of PDLs and IPL for vascular treatment: effects of fluence and pulse duration on a rabbit ear model.Frontiers in medicine · 2026Article
- Current Trends and Future Insights on Rosacea Treatment: A Bibliometric Analysis.Clinical, cosmetic and investigational dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundErythematotelangiectatic rosacea (ETR) is a chronic dermatological condition characterized by persistent facial erythema and visible telangiectasia. This study aims to compare the efficacy, safety, and patient satisfaction associated with pulsed dye laser (PDL), narrow-band intense pulsed light (NB-IPL), and broad-band IPL (BB-IPL) in the treatment of ETR.
methodsA total of 112 patients diagnosed with ETR between May 2021 and April 2024 were retrospectively analyzed. Patients were divided into three treatment groups: PDL (n = 36), NB-IPL (n = 38), and BB-IPL (n = 38). Treatment outcomes were assessed via VISIA imaging, the Clinical Erythema Assessment (CEA), the Rosacea Quality of Life scale (RosaQoL), and recurrence rates. Pain intensity was measured using the Visual Analogue Scale (VAS), and skin parameters were analyzed pre- and post-treatment. Correlation analyses were performed to assess associations between treatment modalities, efficacy, and safety profiles.
resultsNB-IPL significantly reduced erythema and porphyrin levels compared to PDL and BB-IPL (
conclusionNB-IPL demonstrated superior efficacy in erythema reduction, while BB-IPL effectively reduced sebum production but carried a higher risk of pigmentation. PDL provided a balanced therapeutic profile, combining satisfactory efficacy with fewer adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.